Meningitis Flashcards

1
Q

Typical CSF Findings in patients with Bacterial meningitis

A

i) High WBCs (mostly PMNs)
ii) High Protein
iii) Low Glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Typical CSF Findings in patients with Viral meningitis

A

i) High WBC
ii) High protein
iii) Normal Glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a) Fever, headache, and photophobia less neck stiffness and altered mental status
b) Incidence highest during first year of life
c) CSF increase in lymphocytes and monocytes, slight increase in protein, and normal glucose.
d) PCR confirmation- not necessary.
e) Supportive therapy and recover on their own, but can be fatal in neonatal period

A

10) Aseptic Meningitis Syndrome (often Viral but could be noninfectious including some antibiotics TMP-SMX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

11) >85% of viral meningitis are associated with

A

enteroviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

a) “pico” for small, “rna”
b) summer and fall
c) Transmitted hand to mouth
d) Genome organization
e) Single stranded
f) (+) sense RNA
g) Capsid symmetry
h) Icosahedral
i) No Envelope (Naked)

A

12) Enterovirus/Picornavirus Coxsackie, ECHO viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

a) Fever, stiff neck, irritability, and neurologic dysfunction.
b) Acute onset and progression.
c) Big three:
i) Streptococcus pneumonia (pneumococcal)
ii) Neisseria meningiditis (meningococcal)
iii) Haemophilus influenza type b
d) Meningeal inflammation associated with inflammatory exudate in the CSF containing many polymorphonuclear leukocytes, increased protein, and decreased glucose.
e) Life-threating and requires prompt empiric antibiotic therapy.

A

13) Septic Meningitis (Bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

14) Bacterial meningitis treatment

A

a) Immediate empiric treatment with Ceftriaxone or cefotaxime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

– 3rd gen cephalosporins, beta-lactam

a) Mechanism: Bind to penicillin binding proteins (transpeptidases) to inhibit cell-wall synthesis
b) Spectrum: Broad, used for streptococci and more serious Gram- infections, Can cross blood brain barrier
c) Resistance: inactivation of the drug by beta-lactamases, change in penicillin binding protein
d) Side effects: allergies, seizures

A

15) Ceftriaxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

a) Endotoxin is shed from outer cell membrane of Gram negative bacteria
b) Neisseria meningitides structure slightly different called lipooligosacchride (LOS), which mimics brain sphingolipids so recognized as self
c) LPS activates macrophages leading to release of NO(hypotension, Shock) and IL-1(fever), and can activate disseminated intravascular coagulation leading to purpuric skin rash.

A

18) Lipopolysaccharide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

a) Gram negative, diplococcus
c) Virulence factors include pili, IgA protease, capsule, and endotoxin
e) Transmit through respiratory droplets
f) LOS leads to thrombocytopenia, associated with disseminate intravascular coagulation leading to hemorrhagic skin rash- doesn’t fade under pressure.
g) Definitive and prophylactic treatment with ceftriaxone

A

19) Neisseria meningitidis -Meningococcal meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

a) Gram positive diplococci, lancet shape
b) Transmitted through respiratory droplets
c) Meningitis is secondary to paranasal sinusitis and otitis media
d) Most common cause of meningitis > 2 months old
f) 19A-resistant S. pneumoniae treat with vancomycin
g) Heptavalent protein-conjugate vaccine

A

20) Streptococcus pneumonia- Pneumococcal meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

a) Gram- “Coccoid” rod
b) Disease occurs in unvaccinated infants and young children.
c) Virulence factors include pili, outer membrane proteins, IgA protease and endotoxin.
e) Prevention with Hib vaccine- B capsular polysaccharide.

A

21) Hemophilus influenza type b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a) Gastrointestinal and genitourinary tract flora
b) Vertical transmission to infant: in utero or during vaginal delivery
c) given Penicillin G as prophylactic
g) Bacitracin resistant, catalase negative, CAMP reaction (synergistic hemolysis of red blood cells by phopholipase of GBS and B-hemolysin of S. aureus)

A

23) Group B streptococcus aka Streptococcus agalactiae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gram negative, rod

a) Infants, immunocompromised
b) Enteric organism, bacteremia, and transcellular permeation of blood brain barrier
c) LPS, K1 capsular polysaccharide prevents fusion with lysosome
d) If expressing beta-lactamase, ceftriaxone may not be sufficient switch to carbapenem

A

24) Escherichia coli K1 strains- Gram negative, rod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gram positive, rod

a) Immunosuppressed, pregnancy, older adults, newborns
b) Consumption of contaminated food- unpasteurized milk, cheese, and deli meats
c) Fever, headache, no nuchal rigidity, diarrhea
d) Intracellular bacteria, internalin induces phagocytosis by epithelial cells of intestine, phospholipase and listeriolysin O allow escape from vacuole, actin tails facilitate spread between adjacent cells.
e) 50% of blood tests come back negative
f) Definitive therapy with Ampicillin + Gentamicin for 3 weeks.

A

25) Listeria monocytogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

a) 25% of the cases have meningeal involvement.
b) Gradual onset beginning with a generalized illness.
c) More common with increase in immunocompromised individuals
d) Acid fast bacilli stain (Ziehl-Neelsen) and culture
e) Treatment with rifampin, isoniazid, pyrazinamide and ethambutol (RIPE)

A

27) Mycobacterium tuberculosis

17
Q

e) Treatment with rifampin, isoniazid, pyrazinamide and ethambutol (RIPE)

A

27) Mycobacterium tuberculosis

18
Q

inhibits DNA-dependent RNA polymerase induces the formation of drug-metabolizing enzymes including cytochrome P450.

A

i) Rifampin

19
Q

inhibits mycolic acids (component of mycobacterial cell wall). Acetylation by the liver varies genetically and fast acetylators may require higher dose.

A

ii) Isoniazid

20
Q

inhibits cell wall synthesis by binding arabinosyl transferase

A

iv) Ethambutol

21
Q

inhaled as spores and can disseminate hematogenously to CNS in immunocompromised individuals
a) Treatment: Liposomal Amphotericin + Flucytosine until culture negative followed by fluconazole

A

28) Cryptococcus neoformans

22
Q

Binds ergosterol creating holes in fungi membrane allowing leakage of electrolytes. (used to treat fungal meningitis)

A

a) Amphotericin

23
Q

Antimetabolite selectively taken up and converted to 5-fluorouracil in fungi, interferes with DNA and RNA syntheses. (used to treat fungal meningitis)

A

b) Flucytosine

24
Q

binds fungal P-450 enzyme blocks production of ergosterol and is associated with drug-drug interactions.

A

c) Fluconazole